Back to News

Follow the Live #NephTrials Discussion on Spironolactone and its Impact on Dialysis Patients: Join on September 28 @ 9 p.m. EST

The #NephTrials initiative is an exciting series of conversations combining expertise from:

Join us on September 28, 2021, at 9 p.m. EST to discuss:
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE), evaluating if spironolactone reduces heart failure and heart-related deaths in dialysis patients.

Discussion focus:
Run-in periods: useful or threat to generalizability and biased results?

  • Trial representative: Michael Walsh
  • ISN-ACT: Roberto Pecoits-Filho
  • NephJC: Manasi Bapart and Swapnil Hiremath
  • Blogger: Manasi Bapart

To access the discussion:

  • Follow @NephJC and @ISNkidneycare
  • Enter “NephTrials” in Twitter’s search bar
  • Go to “latest”
  • Follow the conversation
    #NephTrials #NephJC

Or consult ISN’s easy-to-follow infographic here to help you join the conversation in a few clicks.

Help us advance kidney health worldwide
Join the ISN Subscribe to ISN Newsletter
Back to News